ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,542,000 | +11.0% | 620,001 | -3.4% | 0.00% | – |
| Q4 2021 | $2,290,000 | -38.8% | 641,653 | -37.6% | 0.00% | -100.0% |
| Q3 2021 | $3,740,000 | -47.0% | 1,027,527 | -36.5% | 0.00% | 0.0% |
| Q2 2021 | $7,050,000 | +5.8% | 1,617,104 | -0.3% | 0.00% | 0.0% |
| Q1 2021 | $6,665,000 | +167.5% | 1,621,499 | +159.6% | 0.00% | – |
| Q4 2020 | $2,492,000 | +296.2% | 624,507 | +168.1% | 0.00% | – |
| Q3 2020 | $629,000 | -15.6% | 232,937 | -14.0% | 0.00% | – |
| Q2 2020 | $745,000 | -73.4% | 270,774 | -77.2% | 0.00% | -100.0% |
| Q1 2020 | $2,802,000 | -57.5% | 1,187,671 | -15.2% | 0.00% | -50.0% |
| Q4 2019 | $6,587,000 | +115.5% | 1,401,379 | +53.3% | 0.00% | +100.0% |
| Q3 2019 | $3,057,000 | -4.0% | 913,913 | -5.5% | 0.00% | 0.0% |
| Q2 2019 | $3,184,000 | -50.7% | 967,520 | -54.6% | 0.00% | -50.0% |
| Q1 2019 | $6,457,000 | +190.7% | 2,130,832 | +160.9% | 0.00% | +100.0% |
| Q4 2018 | $2,221,000 | -13.1% | 816,830 | +7.4% | 0.00% | 0.0% |
| Q3 2018 | $2,557,000 | +52.8% | 760,870 | +17.3% | 0.00% | – |
| Q2 2018 | $1,673,000 | +14.4% | 648,649 | -2.4% | 0.00% | – |
| Q1 2018 | $1,463,000 | -7.3% | 664,736 | -16.2% | 0.00% | – |
| Q4 2017 | $1,578,000 | -41.3% | 793,598 | -4.4% | 0.00% | -100.0% |
| Q3 2017 | $2,690,000 | +55.0% | 830,309 | +54.1% | 0.00% | 0.0% |
| Q2 2017 | $1,735,000 | -69.3% | 538,924 | -72.9% | 0.00% | 0.0% |
| Q1 2017 | $5,658,000 | +208.5% | 1,992,226 | +153.3% | 0.00% | – |
| Q4 2016 | $1,834,000 | +4856.8% | 786,558 | +3542.3% | 0.00% | – |
| Q3 2016 | $37,000 | -58.9% | 21,595 | -74.8% | 0.00% | – |
| Q2 2016 | $90,000 | -96.1% | 85,764 | -96.8% | 0.00% | -100.0% |
| Q1 2016 | $2,303,000 | +1920.2% | 2,647,487 | +2723.3% | 0.00% | – |
| Q4 2015 | $114,000 | +119.2% | 93,772 | +208.5% | 0.00% | – |
| Q3 2015 | $52,000 | -93.0% | 30,396 | -91.5% | 0.00% | – |
| Q2 2015 | $746,000 | +1164.4% | 358,931 | +1516.7% | 0.00% | – |
| Q1 2015 | $59,000 | -69.3% | 22,202 | -70.4% | 0.00% | – |
| Q4 2014 | $192,000 | +910.5% | 75,118 | +644.1% | 0.00% | – |
| Q3 2014 | $19,000 | -72.1% | 10,095 | -60.3% | 0.00% | – |
| Q2 2014 | $68,000 | +13.3% | 25,406 | +47.6% | 0.00% | – |
| Q1 2014 | $60,000 | -15.5% | 17,208 | +6.9% | 0.00% | – |
| Q4 2013 | $71,000 | -81.1% | 16,097 | -82.6% | 0.00% | – |
| Q3 2013 | $375,000 | +65.2% | 92,449 | +69.8% | 0.00% | – |
| Q2 2013 | $227,000 | – | 54,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|